Search

Search Constraints

You searched for: Author/Creator Saad, Fred

Search Results

11. Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 3 (March 2019)

12. Adherence to guideline recommendations for multimodality treatment of patients with pT2–3 M0 non‐urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes. (14th March 2020)

14. Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study. Issue 11 (November 2021)

15. Assessment of other‐cause mortality in localized renal cell carcinoma patients within 15 years: A population‐based analysis. Issue 7 (18th August 2020)

16. Assessment of the optimal number of positive biopsy cores to discriminate between cancer‐specific mortality in high‐risk versus very high‐risk prostate cancer patients. Issue 14 (26th July 2021)